These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 16956518)

  • 1. [Two HHV8-related illnesses in a HIV-negative patient: Kaposi's sarcoma and multicentric Castleman's disease. Response to treatment with Rituximab and CHOP].
    Pastor MA; Vasco B; Mosquera JM; Debén G; Bautista P; Requena L
    Actas Dermosifiliogr; 2006; 97(6):385-90. PubMed ID: 16956518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma.
    Nicoli P; Familiari U; Bosa M; Allice T; Mete F; Morotti A; Cilloni D; Saglio G; Guerrasio A
    Int J Hematol; 2009 Oct; 90(3):392-396. PubMed ID: 19756920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient.
    Murphy C; Hawkes E; Chionh F; Chong G
    J Clin Pharm Ther; 2017 Feb; 42(1):111-114. PubMed ID: 27790727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Kaposi's sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient.
    Law AB; Ryan G; Lade S; Prince HM
    Int J Hematol; 2010 Mar; 91(2):347-8; author reply 349. PubMed ID: 20146033
    [No Abstract]   [Full Text] [Related]  

  • 5. Multicentric Castleman's disease and Kaposi's sarcoma in a cyclosporin treated, HIV-1 negative patient: case report.
    Bollen J; Polstra A; Van Der Kuyl A; Weel J; Noorduyn L; Van Oers M; Cornelissen M
    BMC Blood Disord; 2003 Dec; 3(1):3. PubMed ID: 14670091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentric Castleman's disease in HIV infection: a systematic review of the literature.
    Mylona EE; Baraboutis IG; Lekakis LJ; Georgiou O; Papastamopoulos V; Skoutelis A
    AIDS Rev; 2008; 10(1):25-35. PubMed ID: 18385778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manifestations of three HHV-8-related diseases in an HIV-negative patient: immunoblastic variant multicentric Castleman's disease, primary effusion lymphoma, and Kaposi's sarcoma.
    Codish S; Abu-Shakra M; Ariad S; Zirkin HJ; Yermiyahu T; Dupin N; Boshoff C; Sukenik S
    Am J Hematol; 2000 Dec; 65(4):310-4. PubMed ID: 11074561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.
    Parravicini C; Corbellino M; Paulli M; Magrini U; Lazzarino M; Moore PS; Chang Y
    Am J Pathol; 1997 Dec; 151(6):1517-22. PubMed ID: 9403701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human herpesvirus-8 in lymphomatous and nonlymphomatous body cavity effusions developing in Kaposi's sarcoma and multicentric Castleman's disease.
    Ascoli V; Sirianni MC; Mezzaroma I; Mastroianni CM; Vullo V; Andreoni M; Narciso P; Scalzo CC; Nardi F; Pistilli A; Lo Coco F
    Ann Diagn Pathol; 1999 Dec; 3(6):357-63. PubMed ID: 10594287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KSHV/HHV8-associated primary cutaneous plasmablastic lymphoma in a patient with Castleman's disease and Kaposi's sarcoma.
    Liu W; Lacouture ME; Jiang J; Kraus M; Dickstein J; Soltani K; Shea CR
    J Cutan Pathol; 2006 Sep; 33 Suppl 2():46-51. PubMed ID: 16972955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete remission in a pancytopenic HIV negative, HHV-8 positive patient with multicentric Castleman's disease induced with anti-CD20.
    Cervera Grau JM; Galiana Esquerdo G; Llorca Ferrándiz C; Briceño García H; Díaz Castellano M; Férriz Moreno P
    Clin Transl Oncol; 2006 Jul; 8(7):540-1. PubMed ID: 16870545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous Kaposi's sarcoma and Castleman's disease in a HIV-negative patient. Response to rituximab and doxorubicin.
    García-Arpa M; Calle-Primo C; Martín-Dávila F
    Med Clin (Barc); 2020 Dec; 155(12):565-566. PubMed ID: 31759694
    [No Abstract]   [Full Text] [Related]  

  • 13. Multicentric Castleman's disease in association with Kaposi's sarcoma.
    De Rosa G; Barra E; Guarino M; Gentile R
    Appl Pathol; 1989; 7(2):105-10. PubMed ID: 2730798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab-containing Chemotherapy (R-CHOP)-induced Kaposi's Sarcoma in an HIV-negative Patient with Diffuse Large B Cell Lymphoma.
    Ureshino H; Ando T; Kojima K; Itamura H; Jinnai S; Doi K; Ohshima K; Kurogi K; Miyahara M; Kimura S
    Intern Med; 2015; 54(24):3205-8. PubMed ID: 26666614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic options for human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus-related disorders.
    Aoki Y; Tosato G
    Expert Rev Anti Infect Ther; 2004 Apr; 2(2):213-25. PubMed ID: 15482187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first reported case and management of multicentric Castleman's disease associated with Kaposi's sarcoma in an HIV-2-infected patient.
    Bouvresse S; Marcelin AG; Franck N; Regnier S; Damond F; Tulliez M; Dupin N
    AIDS; 2007 Jul; 21(11):1492-4. PubMed ID: 17589201
    [No Abstract]   [Full Text] [Related]  

  • 17. Multicentric Castleman's Disease and Kaposi's Sarcoma in a HIV-Positive Patient on Highly Active Antiretroviral Therapy.
    Ortega L; Cooper CJ; Otoukesh S; Mojtahedzadeh M; Didia CS; Torabi A; Nahleh Z
    Rare Tumors; 2014 Jul; 6(3):5480. PubMed ID: 25276327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Herpesvirus Type 8-positive Multicentric Castleman Disease.
    Melikyan AL; Egorova EK; Julhakyan HL; Kovrigina AL; Savchenko VG
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S159-65. PubMed ID: 27133959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of human herpesvirus 8 by real-time PCR in blood fractions of AIDS patients with Kaposi's sarcoma and multicentric Castleman's disease.
    Boivin G; Côté S; Cloutier N; Abed Y; Maguigad M; Routy JP
    J Med Virol; 2002 Nov; 68(3):399-403. PubMed ID: 12226828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Herpes Virus 8 in HIV-1 infected individuals receiving cancer chemotherapy and stem cell transplantation.
    Hogan LE; Hanhauser E; Hobbs KS; Palmer CD; Robles Y; Jost S; LaCasce AS; Abramson J; Hamdan A; Marty FM; Kuritzkes DR; Henrich TJ
    PLoS One; 2018; 13(5):e0197298. PubMed ID: 29746555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.